Invention Grant
US08951964B2 Phenanthridine macrocyclic hepatitis C serine protease inhibitors
有权
菲尼丁胺大环内酯类丙型肝炎丝氨酸蛋白酶抑制剂
- Patent Title: Phenanthridine macrocyclic hepatitis C serine protease inhibitors
- Patent Title (中): 菲尼丁胺大环内酯类丙型肝炎丝氨酸蛋白酶抑制剂
-
Application No.: US13339448Application Date: 2011-12-29
-
Publication No.: US08951964B2Publication Date: 2015-02-10
- Inventor: Keith F. McDaniel , Hui-Ju Chen , Jason P. Shanley , David J. Grampovnik , Brian Green , Timothy Middleton , Todd Hopkins , Yat Sun Or
- Applicant: Keith F. McDaniel , Hui-Ju Chen , Jason P. Shanley , David J. Grampovnik , Brian Green , Timothy Middleton , Todd Hopkins , Yat Sun Or
- Applicant Address: US IL North Chicago US MA Watertown
- Assignee: AbbVie Inc.,Enanta Pharmaceuticals, Inc.
- Current Assignee: AbbVie Inc.,Enanta Pharmaceuticals, Inc.
- Current Assignee Address: US IL North Chicago US MA Watertown
- Agency: Edwards Wildman Palmer LLP
- Agent Jeffrey D. Hsi; Stephen W. Rafferty
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A01N37/18 ; C07D487/04
Abstract:
The present invention relates to novel macrocyclic compounds and methods of treating a hepatitis C infection in a subject in need of such therapy with said macrocyclic compounds. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient.
Public/Granted literature
- US20120295842A1 PHENANTHRIDINE MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS Public/Granted day:2012-11-22
Information query
IPC分类:
